Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Bladder cancer laboratory tests
Introduction
Overview
Overview
Laboratory findings consistent with the diagnosis of bladder cancer include blood in the urine and abnormal cells in urine cytology. [Tumor marker]] tests include ladder tumour–associated antigen (BTA), uclear matrix proteins (NMP) and mucin and carcinoembryonic antigen (CEA).
Laboratory Findings
Laboratory Findings
- Laboratory findings consistent with the diagnosis of bladder cancer include:[1][2][3]
- Complete blood count
- Low red blood cell count
- Elevated alkaline phosphatase
- Hematuria
- Urine cytology
- Abnormal cells in the urine
- Tumor marker tests
- Bladder tumour–associated antigen (BTA)
- Nuclear matrix proteins (NMP)
- Mucin and carcinoembryonic antigen (CEA)
References
References
- ↑ Shariat SF, Karam JA, Lotan Y, Karakiewizc PI (2008). “Critical evaluation of urinary markers for bladder cancer detection and monitoring”. Rev Urol. 10 (2): 120–35. PMC 2483317. PMID 18660854.
- ↑ Villicana P, Whiting B, Goodison S, Rosser CJ (June 2009). “Urine-based assays for the detection of bladder cancer”. Biomark Med. 3 (3): 265. doi:10.2217/bmm.09.23. PMC 2819730. PMID 20161673.
- ↑ Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR (April 2001). “Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy–part I: definition, detection, prevalence, and etiology”. Urology. 57 (4): 599–603. PMID 11306356.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Farima Kahe M.D. [2], Shanshan Cen, M.D. [3]